Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 105
Filtrar
1.
Clin Oral Investig ; 28(7): 375, 2024 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-38878120

RESUMO

OBJECTIVE: To investigate the impact of mineralized dentin matrix (MDM) on the prognosis on bone regeneration and migration of retained roots after coronectomy. MATERIALS AND METHODS: Patients were divided into three groups based on the type of bone graft after coronectomy: Group C (n = 20, collagen), Group T (n = 20, tricalcium phosphate (TCP) + collagen), and Group D (n = 20, MDM + collagen). CBCT scans, conducted immediately and 6 months after surgery, were analyzed using digital software. Primary outcomes, including changes in bone defect depth and retained root migration distance, were evaluated 6 months after surgery. RESULTS: After 6 months, both Groups D and T exhibited greater reduction of the bone defect and lesser retained root migration than Group C (p < 0.001). Group D had greater regenerated bone volume in the distal 2 mm (73 mm3 vs. 57 mm3, p = 0.011) and lesser root migration (2.18 mm vs. 2.96 mm, p < 0.001) than Group T. The proportion of completely bone embedded retained roots was also greater in Group D than in Group C (70.0% vs. 42.1%, p = 0.003). CONCLUSIONS: MDM is an appropriate graft material for improving bone defect healing and reducing retained root migration after coronectomy. CLINICAL RELEVANCE: MDM is an autogenous material prepared chairside, which can significantly improve bone healing and reduce the risk of retained root re-eruption. MDM holds promise as a routine bone substitute material after M3M coronectomy.


Assuntos
Regeneração Óssea , Fosfatos de Cálcio , Colágeno , Tomografia Computadorizada de Feixe Cônico , Dentina , Humanos , Masculino , Feminino , Fosfatos de Cálcio/uso terapêutico , Prognóstico , Pessoa de Meia-Idade , Colágeno/uso terapêutico , Regeneração Óssea/efeitos dos fármacos , Raiz Dentária/diagnóstico por imagem , Raiz Dentária/cirurgia , Adulto , Coroa do Dente/cirurgia , Resultado do Tratamento , Transplante Ósseo/métodos , Substitutos Ósseos/uso terapêutico
2.
BMC Musculoskelet Disord ; 24(1): 40, 2023 Jan 18.
Artigo em Inglês | MEDLINE | ID: mdl-36650473

RESUMO

BACKGROUND: This study was aimed to investigate whether the application of platelet-rich plasma (PRP) combined with ß-tri-calcium phosphate (ß-TCP) grafts after core decompression (CD) could improve the clinical outcomes of early stage of avascular necrosis of femoral head. METHODS: Forty-five (54 hips) patients with Ficat-Arlet classification stage I-II treated by CD with ß-TCP grafts with or without the application of PRP from July 2015 to October 2020 were reviewed. Group A (CD + ß-TCP grafts) included 24 patients (29 hips), while group B (CD + ß-TCP grafts + PRP) included 21 patients (25 hips). Visual analogue scale (VAS) score, Harris hip score (HHS), change in modified Kerboul angle and the hip joint survival were evaluated and compared between the groups. Patients had a mean follow-up period of 62.1 ± 17.2 months and 59.3 ± 14.8 months in group A and group B, respectively. RESULTS: The mean VAS scores in group A was significantly higher than group B at the 6 months (2.9 ± 0.7 vs 1.9 ± 0.6, p < 0.01) and final follow up postoperative (2.8 ± 1.2 vs 2.2 ± 0.7, p = 0.04). The mean HHS in group A was significantly lower than group B at the 6 months (80.5 ± 13.8 vs 89.8 ± 12.8, p = 0.02). However, at the final follow up, there is no significant difference between the groups (77.0 ± 12.4 vs 83.1 ± 9.3, p = 0.07). The mean change in modified Kerboul angle was -7.4 ± 10.6 in group A and -19.9 ± 13.9 in group B which is statistically significant (p < 0.01). Survivorship from total hip arthroplasty were 86.2%/84% (p = 0.86) at the final follow up, which was not statistically significant. No serious complications were found in both groups. CONCLUSIONS: A single dose of PRP combined with CD and ß-TCP grafts provided significant pain relief, better functional outcomes, and delayed progression in the short term compared to CD combined with ß-TCP grafts. However, the prognosis of the femoral head did not improve significantly in the long term. In the future, designing new implants to achieve multiple PRP injections may improve the hip preservation rate.


Assuntos
Necrose da Cabeça do Fêmur , Plasma Rico em Plaquetas , Humanos , Necrose da Cabeça do Fêmur/diagnóstico por imagem , Necrose da Cabeça do Fêmur/cirurgia , Resultado do Tratamento , Cabeça do Fêmur/diagnóstico por imagem , Cabeça do Fêmur/cirurgia , Descompressão Cirúrgica/efeitos adversos , Fosfatos de Cálcio/uso terapêutico , Transplante Ósseo/efeitos adversos
3.
BMC Oral Health ; 21(1): 219, 2021 04 29.
Artigo em Inglês | MEDLINE | ID: mdl-33926447

RESUMO

BACKGROUND: Beta-tricalcium phosphate in regenerative surgery has shown promising results in terms of bone gain and new vital bone formation; however, several studies have contradicted this finding. The aim of this study was to evaluate the effectiveness of beta-tricalcium phosphate compared to other grafting materials in the regeneration of periodontal infra-bony defects. METHODS: Electronic database (Cochrane, MEDLINE, PubMed, Embase, Science Citation Index Expanded) and manual searches for related data were performed up until March 2020. The outcomes were pocket depth reduction, clinical attachment level gain, and amount of bone fill. RESULTS: Five studies were selected based on the inclusion criteria. Bone regeneration with beta-tricalcium phosphate was observed to be superior to that with debridement alone but showed comparable results to other bone graft materials in terms of pocket depth reduction, clinical attachment level gain, and bone fill. Regenerative procedures for periodontal infra-bony defects that used beta-tricalcium phosphate in combination with other growth factors yielded superior outcomes. The meta-analysis revealed that for cases with two-wall defects, the use of beta-tricalcium phosphate yielded statistically significant differences in pocket depth reduction and clinical attachment level gain, but not in bone fill. CONCLUSIONS: Beta-tricalcium phosphate appears to be a promising material for use in periodontal infra-bony defect regeneration around natural teeth. However, randomized clinical trials with larger sample sizes and more controlled study designs are needed to support these findings.


Assuntos
Perda do Osso Alveolar , Substitutos Ósseos , Perda do Osso Alveolar/cirurgia , Regeneração Óssea , Substitutos Ósseos/uso terapêutico , Fosfatos de Cálcio/uso terapêutico , Regeneração Tecidual Guiada Periodontal , Humanos , Perda da Inserção Periodontal/cirurgia , Resultado do Tratamento
4.
Niger J Clin Pract ; 23(7): 1026-1029, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-32620736

RESUMO

When teeth have responded poorly to conventional endodontic treatment or when they cannot be treated adequately by nonsurgical means, surgical endodontics remains the treatment of choice. Healing of apical lesions occurs by repair, most of the time. "Repair is the healing of a wound by tissue that does not fully restore the architecture or function of the affected unit". Since this is not ideal, newer regenerative procedures that aim to restore lost tissue have been introduced. ß -Tricalcium phosphate is an alloplastic bone graft material that forms a scaffold for closing the bony defect. It is osteoconductive. Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) are platelet concentrates, rich in growth factors and they promote regeneration by osteoinduction. This article describes cases of bone augmentation with a combination of PRP + ß -TCP and PRF + ß -TCP for treatment of the chronic periapical lesion. The cases were followed for six months and one year and healing was evaluated quantitatively using cone beam computed tomography.


Assuntos
Fosfatos de Cálcio/uso terapêutico , Tomografia Computadorizada de Feixe Cônico/métodos , Fibrina Rica em Plaquetas , Plasma Rico em Plaquetas , Adulto , Regeneração Óssea , Transplante Ósseo , Feminino , Humanos , Radiografia Dentária , Ápice Dentário/diagnóstico por imagem , Ápice Dentário/cirurgia , Colo do Dente/patologia , Resultado do Tratamento , Cicatrização
5.
BMC Oral Health ; 19(1): 113, 2019 06 14.
Artigo em Inglês | MEDLINE | ID: mdl-31200708

RESUMO

BACKGROUND: To compare different anti-caries agents on microhardness and micromorphology of irradiated permanent dentin in vitro, and try to find the most effective agent to prevent radiation-dentin-destruction. METHODS: A total of 120 dentin samples were prepared from 60 human teeth and randomly divided into 8 groups (n = 15), [ (1)] blank control [2]; irradiation control [3]; irradiation+ fluoride [4]; irradiation+ casein phosphate polypeptide-amorphous calcium phosphate (CPP-ACP) [5]; irradiation+ CPP-ACP+ fluoride [6]; irradiation+ infiltration resin [7]; irradiation+ infiltration resin+ fluoride [8]; irradiation+ infiltration resin+ CPP-ACP. Seven samples of each groups were chosen randomly for microhardness test and eight for scanning electron microscope observation. RESULTS: A decrease of microhardness (P < 0.05) and an obvious morphological change were presented on dentin surface after radiotherapy. After applications of anti-caries agents, the morphological destructions were effectively restored. The infiltration resin plus fluoride group (56.00 ± 4.02 Kg/mm2), infiltration resin plus CPP-ACP group (56.05 ± 3.69 Kg/mm2), infiltration resin group (54.70 ± 4.42Kg/mm2) and CPP-ACP plus fluoride group (53.84 ± 6.23Kg/mm2) had the highest dentin microhardness value after radiotherapy, and no statistically significant difference were found between them. CONCLUSIONS: Infiltration resin, CPP-ACP, fluoride and their pairwise combination can effectively prevent radiation-dentin-destruction. Among them, infiltration resin with CPP-ACP, infiltration resin with fluoride, CPP-ACP with fluoride, and infiltration resin have the most protective effects on irradiation-dentin-destructions.


Assuntos
Fosfatos de Cálcio/uso terapêutico , Caseínas , Cárie Dentária/prevenção & controle , Dentina/efeitos dos fármacos , Fluoretos/uso terapêutico , Fosfatos de Cálcio/administração & dosagem , Humanos
6.
Morphologie ; 101(334): 173-179, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28501353

RESUMO

Autogenous bone graft (autograft) remains the gold standard in the treatment of many orthopedic problems. However, graft harvest can lead to perioperative morbidity and increased cost. We tested the hypothesis that an osteoconductive matrix, beta-tricalcium phosphate (ß-TCP), would be a safe and effective alternative to autograft alone. Beta-tricalcium phosphate (ß-TCP) is considered as one of the most promising biomaterials for bone reconstruction. This study analyzes the outcomes of patients who received ß-TCP as bone substitutes in orthopedic surgery. METHODS: A total of 50 patients were enrolled in a controlled, non-inferiority clinical trial to compare the safety and efficacy of ß-TCP (25 patients) with those of autograft (25 patients) in indications requiring usually autograft. These 50 patients were categorized according to the etiology and morphology of the 54 bone defects resulting from elective surgical procedures, such as 34 open-wedge high tibial osteotomies, and 20 osteonecrosis treatments with core decompression. Radiographic (healing process with or without integration of ß-TCP), clinical (no other surgical procedure), functional outcomes and safety (with or without complications) were assessed through fifty-two weeks postoperatively. RESULTS: With regard to the primary endpoint (radiographic evolution), the fusion rate of the 34 open-wedge osteotomies was 100% (17 among 17) for patients in the group with ß-TCP compared with 94% (16 among 17) for patients in the autograft group. For the 20 cavitary defects (osteonecrosis), the radiographic union rates, as determined by the presence of osseous bridging, were 100% for patients in the group with ß-TCP and 100% for those in the autograft group. Clinically at one year, all quality-of-life and functional outcome data supported non-inferiority of ß-TCP compared with autograft, and patients in the ß-TCP group were found to have less pain and an improved safety profile. CONCLUSIONS: Treatment with ß-TCP resulted in comparable fusion rates, less pain and fewer side effects as compared with treatment with autograft. This study established clinical parameters where the ß-TCP alone can successfully support the osteogenic process.


Assuntos
Substitutos Ósseos/uso terapêutico , Transplante Ósseo/efeitos adversos , Osso e Ossos/cirurgia , Fosfatos de Cálcio/uso terapêutico , Procedimentos Ortopédicos/métodos , Procedimentos de Cirurgia Plástica/métodos , Adulto , Regeneração Óssea/efeitos dos fármacos , Substitutos Ósseos/economia , Transplante Ósseo/economia , Transplante Ósseo/métodos , Osso e Ossos/diagnóstico por imagem , Osso e Ossos/lesões , Osso e Ossos/fisiologia , Fosfatos de Cálcio/economia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Procedimentos Ortopédicos/efeitos adversos , Procedimentos Ortopédicos/instrumentação , Osteogênese/efeitos dos fármacos , Osteonecrose/diagnóstico por imagem , Osteonecrose/etiologia , Osteonecrose/cirurgia , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etiologia , Radiografia , Procedimentos de Cirurgia Plástica/efeitos adversos , Transplante Autólogo/efeitos adversos , Transplante Autólogo/economia , Transplante Autólogo/métodos , Resultado do Tratamento , Adulto Jovem
7.
Caries Res ; 49 Suppl 1: 11-7, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25871414

RESUMO

Various caries prevention and repair strategies are reviewed in this article ranging from the use of fluoride to nanohydroxyapatite particles. Several of the strategies which combine fluoride and calcium and phosphate treatments have both in vitro and in vivo data showing them to be efficacious if the surface integrity of the lesion is not breached. Once this has occurred, the rationale for cutting off the nutrient supplies to the pathogenic bacteria without the removal of the infected dentine, a noninvasive restorative technique, is discussed using existing clinical studies as examples. Finally two novel noninvasive restorative techniques using fluorohydroxyapatite crystals are described. The need for clinical data in support of emerging caries-preventive and restorative strategies is emphasized.


Assuntos
Cárie Dentária/prevenção & controle , Fosfatos de Cálcio/uso terapêutico , Cariostáticos/uso terapêutico , Cárie Dentária/terapia , Restauração Dentária Permanente/métodos , Durapatita/uso terapêutico , Fluoretos/uso terapêutico , Humanos , Hidroxiapatitas/uso terapêutico , Nanopartículas/uso terapêutico , Remineralização Dentária/métodos
8.
Clin Nephrol ; 82(6): 372-8, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25295578

RESUMO

BACKGROUND: The effects of lanthanum carbonate (LC) vs. calciumbased phosphate binders in dialysis patients have been a matter of debate. METHODS: We electronically searched PubMed, Embase, CENTRAL, and CBM for all randomized controlled trials comparing LC with calcium-based phosphate binders in adult dialysis patients. Quality assessment was performed using the Cochrane risk of bias tool. Metaanalysis was conducted by RevMan 5.2. RESULTS: Nine studies were eligible for our meta-analysis. There was no significant difference in all-cause mortality (RR 0.84, 95% CI 0.25 - 2.83) and cardiovascular events (RR 0.84, 95% CI 0.55 - 1.29) between LC and calcium-based phosphate binders. LC was associated with similar proportions of phosphate-controlled patients (RR 0.63, 95% CI 0.27 - 1.44) and lower incidence of hypercalcemia (RR 0.13, 95% CI 0.05 - 0.35) in comparison to calcium-based phosphate binders. Compared with calcium salts, LC was associated with significantly lower serum calcium, similar serum Ca x P product and higher serum iPTH. CONCLUSION: Despite the trends observed, we found no statistically significant differences in all-cause mortality and cardiovascular events between LC and calcium-based phosphate binders in dialysis patients. The conclusion was limited by lack of large sample and long-term trials. LC could reduce the incidence of hypercalcemia while comparable with calcium-based phosphate binders in reducing serum phosphorus level.


Assuntos
Fosfatos de Cálcio/uso terapêutico , Quelantes/uso terapêutico , Soluções para Diálise/uso terapêutico , Lantânio/uso terapêutico , Diálise Renal/métodos , Cálcio/sangue , Humanos , Hipercalcemia/prevenção & controle , Hormônio Paratireóideo/sangue , Fósforo/sangue
10.
Eur Cell Mater ; 25: 215-28, 2013 Mar 25.
Artigo em Inglês | MEDLINE | ID: mdl-23529785

RESUMO

Calcium phosphates are used in maxillary sinus floor elevation (MSFE) procedures to increase bone height prior to dental implant placement. Whether a collagenous barrier membrane coverage of the lateral window affects bone formation within a bone substitute augmentation is currently an important matter of debate, since its benefit has not been irrefutably proven. Therefore, in this clinical study twelve patients underwent an MSFE procedure with ß-tricalcium phosphate (ß-TCP). The lateral window was either left uncovered, or covered with a resorbable collagenous barrier membrane. After a 6-months healing period, bone biopsies were retrieved during implant placement. Consecutive 1 mm regions of interest of these biopsies were assessed for bone formation, resorption parameters, as well as bone architecture using histology, histomorphometry and micro-computed tomography. Comparable outcomes between the groups with and without membrane were observed regarding osteoconduction rate, bone and graft volume, osteoclast number and structural parameters of newly formed bone per region of interest. However, osteoid volume in grafted maxillary sinus floors without membrane was significantly higher than with membrane. In conclusion, our results - obtained with a novel method employed using 1 mm regions of interest - demonstrate that the clinical application of a bioresorbable collagenous barrier membrane covering the lateral window, after an MSFE procedure with ß-TCP, was not beneficial for bone regeneration and even decreased osteoid production which might lead to diminished bone formation in the long run.


Assuntos
Substitutos Ósseos/uso terapêutico , Fosfatos de Cálcio/uso terapêutico , Colágeno/uso terapêutico , Levantamento do Assoalho do Seio Maxilar , Perda de Dente/cirurgia , Implantes Absorvíveis , Adulto , Idoso , Regeneração Óssea , Feminino , Humanos , Masculino , Maxila/diagnóstico por imagem , Maxila/patologia , Maxila/cirurgia , Membranas Artificiais , Pessoa de Meia-Idade , Osteoclastos/efeitos dos fármacos , Perda de Dente/diagnóstico por imagem , Perda de Dente/patologia , Resultado do Tratamento , Microtomografia por Raio-X
11.
Eur Spine J ; 22 Suppl 2: S185-94, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22948551

RESUMO

STUDY DESIGN AND OBJECTIVE: The purpose of this prospective clinical study is to evaluate the clinical and radiographic outcomes using a silicate-substituted calcium phosphate (Si-CaP) as a bone graft substitute in surgery for adolescent idiopathic scoliosis (AIS). In posterior corrective surgery for AIS, harvesting autologous bone from the iliac crest still represents the gold standard to augment the local bone graft though it is comparatively invasive and associated with donor site morbidity. Si-CaP enriched with bone marrow aspirate (BMA) might be an appropriate bone graft extender to overcome these difficulties. METHODS: Eighteen female and three male patients with AIS who underwent corrective posterior instrumentation were observed clinically and radiographically for a minimum of 24 months. In all cases, 20-40 ml Si-CaP granules (ACTIFUSE) mixed with BMA from vertebral bodies was used to extend the local bone graft. Fusion was assessed by standardized conventional radiographs regarding loss of correction and implant failure. Clinical outcome was evaluated with use of the Scoliosis Research Society-22 patient Questionnaire (SRS-22) and a Visual Analog Scale (VAS) for back pain. RESULTS: Cobb angle of major curves averaged 63° preoperatively, 22° after surgery, and 24° at final follow-up, with a maximum loss of correction of 7° recorded after 4 months. No adverse effects related to the study material had been observed. In all patients, there was no evidence of implant failure, and formation of an increasingly densifying 'fusion mass' was visible, as assessed by conventional radiography. VAS score for back pain averaged 1.7 before surgery, 2.3 at discharge, and 1.5 at final follow-up. Outcome assessment using the SRS-22 revealed a significantly enhanced overall health-related quality of life (84 vs. 74 % before surgery; P = 0.0005) due to a significant improvement of the domains 'self image' (77 vs. 59 %; P = 0.0002) and 'pain' (88 vs. 80 %; P = 0.02). Patients' management satisfaction averaged 93 %. CONCLUSIONS: Si-CaP augmented with BMA from vertebral bodies seems to prove an effective, safe, and easy to handle bone graft extender in scoliosis surgery and thus a suitable alternative to bone harvesting procedures.


Assuntos
Substitutos Ósseos/uso terapêutico , Transplante Ósseo/métodos , Fosfatos de Cálcio/uso terapêutico , Escoliose/cirurgia , Silicatos/uso terapêutico , Adolescente , Criança , Feminino , Humanos , Masculino , Radiografia , Escoliose/diagnóstico por imagem , Resultado do Tratamento , Adulto Jovem
12.
Neurol Neurochir Pol ; 47(6): 590-4, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24375006

RESUMO

The authors describe the use of bone cement containing calcium phosphate for vertebroplasty of the cavity in the base of odontoid process. A 23-year-old female patient was operated on by incision in lateral cervical area (anterior open access). After a blunt dissection, the working cannula (Kyphon) was introduced under fluoroscopic guidance through the C2 vertebral body to the cavity in the base of the odontoid process. Intraoperatively, biopsy of the lesion was taken and histo-pathological examination excluded the presence of neoplasm. The cavity, presumably haemangioma, was successfully filled with calcium phosphate bone cement KyphOsTM FS (Ky-phon). The proper filling without paravertebral cement leak was confirmed by postoperative computed tomography (CT). The CT and magnetic resonance imaging performed 9 months after the procedure showed that cement was still present in the cavity. This is the first use of calcium phosphate cement to conduct the vertebroplasty of C2 vertebra.


Assuntos
Cimentos Ósseos , Fosfatos de Cálcio/uso terapêutico , Vértebras Cervicais/cirurgia , Hemangioma/cirurgia , Neoplasias da Coluna Vertebral/cirurgia , Vertebroplastia/métodos , Feminino , Hemangioma/patologia , Humanos , Procedimentos Cirúrgicos Minimamente Invasivos , Neoplasias da Coluna Vertebral/patologia , Resultado do Tratamento , Adulto Jovem
13.
Arch Dis Child Educ Pract Ed ; 97(4): 157-63, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22761487

RESUMO

Alkaline phosphatase (ALP) is regularly measured in clinical practice. Changes in serum levels are observed in a number of clinical conditions. In neonatology, it has been proposed as a useful marker for both a diagnosis and an indication of the severity of metabolic bone disease (MBD) in infants born preterm. Nutritional practices, aimed at reducing the occurrence or severity of MBD, have led to ALP being proposed as a stand-alone means of monitoring treatment. The current evidence does not support this use: ALP only achieves usefulness in a diagnostic and monitoring capacity when combined with other serum and imaging techniques.


Assuntos
Fosfatase Alcalina/sangue , Biomarcadores/sangue , Densidade Óssea , Doenças Ósseas Metabólicas/sangue , Doenças Ósseas Metabólicas/diagnóstico , Calcificação Fisiológica , Cálcio/sangue , Fosfatos de Cálcio/uso terapêutico , Colestase/diagnóstico , Humanos , Recém-Nascido , Recém-Nascido Prematuro , Doenças do Prematuro/sangue , Doenças do Prematuro/diagnóstico , Isoenzimas , Alta do Paciente , Fosfatos/sangue , Fósforo/sangue , Vitamina D/uso terapêutico , Vitaminas/uso terapêutico
14.
Adv Dent Res ; 24(2): 48-52, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22899679

RESUMO

With more than 50 years of clinical success, fluoride serves as the gold standard agent for preventing tooth decay. In particular, the action of fluoride facilitates saliva-driven remineralization of demineralized enamel and alters solubility beneficially. Still, tooth decay remains problematic, and one way to address it may be through the development of new mineralizing agents. Laboratory and clinical studies have demonstrated that the combination of fluoride and functionalized ß-tricalcium phosphate (fTCP) produces stronger, more acid-resistant mineral relative to fluoride, native ß-TCP, or fTCP alone. In contrast to other calcium-based approaches that seem to rely on high levels of calcium and phosphate to drive remineralization, fTCP is a low-dose system designed to fit within existing topical fluoride preparations. The functionalization of ß-TCP with organic and/or inorganic molecules provides a barrier that prevents premature fluoride-calcium interactions and aids in mineralization when applied via common preparations and procedures. While additional clinical studies are warranted, supplementing with fTCP to enhance fluoride-based nucleation activity, with subsequent remineralization driven by dietary and salivary calcium and phosphate, appears to be a promising approach.


Assuntos
Fosfatos de Cálcio/uso terapêutico , Cárie Dentária/prevenção & controle , Fluoretos/uso terapêutico , Remineralização Dentária/métodos , Fosfatos de Cálcio/síntese química , Fosfatos de Cálcio/química , Cárie Dentária/terapia , Esmalte Dentário/química , Esmalte Dentário/metabolismo , Fluoretos/química , Humanos
15.
J Oral Implantol ; 38 Spec No: 519-26, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23072285

RESUMO

The choice of augmentation material is a crucial factor in sinus augmentation surgery. Bovine-derived hydroxyapatite (BHA) and beta-tricalcium phosphate (ß-TCP) have been used successfully in sinus augmentation procedures. Choosing one of these materials for sinus augmentation is still controversial. The aim of this clinical study was to compare the biological performance of the new BHA graft material and the well-known synthetic ß-TCP material in the sinus augmentation procedure. The study consisted of 23 patients (12 male and 11 female) who were either edentulous or partially edentulous in the posterior maxilla and required implant placement. A total of 23 two-step sinus-grafting procedures were performed. BHA was used in 13 patients, and ß-TCP was used in 10 patients. After an average of 6.5 months of healing, bone biopsies were taken from the grafted areas. Undecalcified sections were prepared for histomorphometric analysis. The mean new bone formation was 30.13% ± 3.45% in the BHA group and 21.09% ± 2.86% in the ß-TCP group (P = .001). The mean percentage of residual graft particle area was 31.88% ± 6.05% and 34.05% ± 3.01% for the BHA group and ß-TCP group, respectively (P = .047). The mean percentage of soft-tissue area was 37.99% ± 5.92% in the BHA group and 44.86% ± 4.28% in the ß-TCP group (P = .011). Both graft materials demonstrated successful biocompatibility and osteoconductivity in the sinus augmentation procedure. However, BHA appears to be more efficient in osteoconduction when compared with ß-TCP.


Assuntos
Substitutos Ósseos/uso terapêutico , Fosfatos de Cálcio/uso terapêutico , Implantação Dentária Endóssea/métodos , Hidroxiapatitas/uso terapêutico , Osseointegração/efeitos dos fármacos , Levantamento do Assoalho do Seio Maxilar/métodos , Adulto , Animais , Materiais Biocompatíveis/química , Materiais Biocompatíveis/uso terapêutico , Substitutos Ósseos/química , Bovinos , Implantação Dentária Endóssea/instrumentação , Feminino , Humanos , Arcada Edêntula/cirurgia , Arcada Parcialmente Edêntula/cirurgia , Masculino , Maxila/patologia , Maxila/cirurgia , Seio Maxilar/cirurgia , Pessoa de Meia-Idade , Minerais/uso terapêutico , Osteogênese/efeitos dos fármacos , Resultado do Tratamento
16.
Compend Contin Educ Dent ; 33(6): 394-6, 398-402; quiz 404, 416, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22774328

RESUMO

Tools and techniques are available to oral care providers that have been found to be effective in reversing and controlling the caries process. In addition to fluoride, these tools include new remineralization therapies that can be incorporated into solutions, creams, and dentifrices, and bioactive restorative materials that work effectively with dental hard tissues. By incorporating such "proactive interventions" into their practice and educating patients on maintaining a daily oral hygiene regimen, clinicians can inhibit the multifactorial disease process of demineralization and caries before more extensive treatment becomes necessary.


Assuntos
Cariostáticos/uso terapêutico , Cárie Dentária/prevenção & controle , Fluoretos/uso terapêutico , Remineralização Dentária/métodos , Compostos de Cálcio/uso terapêutico , Fosfatos de Cálcio/uso terapêutico , Caseínas/uso terapêutico , Fluoretos/metabolismo , Vidro , Cimentos de Ionômeros de Vidro/uso terapêutico , Humanos , Concentração de Íons de Hidrogênio , Higiene Bucal/métodos , Cimento de Silicato/uso terapêutico , Silicatos/uso terapêutico , Xilitol/uso terapêutico
17.
J Can Dent Assoc ; 77: b85, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21774875

RESUMO

Patients with xerostomia, or dry mouth, resulting from various causes, are at higher risk for developing caries because of a loss of saliva and its benefits. A loss of saliva increases the acidity of the mouth, which affects many factors that contribute to the development of caries, such as proliferation of acid-producing bacteria, inability to buffer the acid produced by bacteria or from ingested foods, loss of minerals from tooth surfaces and inability to replenish the lost minerals, and loss of lubrication. Currently, a number of new products that can substitute for these functions of saliva or induce production of saliva are available in Canada. Some of these products are reviewed and a protocol for caries prevention in this high-risk population is proposed.


Assuntos
Cárie Dentária/prevenção & controle , Xerostomia/complicações , Fosfatos de Cálcio/uso terapêutico , Cariostáticos/uso terapêutico , Caseínas/uso terapêutico , Vidro , Humanos , Antissépticos Bucais/uso terapêutico , Saliva/fisiologia , Saliva Artificial/uso terapêutico , Fluoreto de Sódio/uso terapêutico , Fluoretos de Estanho/uso terapêutico , Remineralização Dentária/métodos , Escovação Dentária/métodos , Cremes Dentais/uso terapêutico , Xilitol/uso terapêutico
18.
J Prosthet Dent ; 105(3): 147-53, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21356405

RESUMO

This clinical report presents a simplified surgical procedure for accessing the maxillary sinus antrum via lateral and crestal approaches, which reduces the potential for sinus membrane perforation and subsequent complications when graft materials and dental implants are placed into the sinus. Due to visual limitations, perforations and associated complications can jeopardize the success rate of the graft and the implants. While there is a lack of clinical data, clinical observations suggest that the procedure, described by the authors as lateral/crestal bone planing antrostomy, can reduce the possibility of perforation of the maxillary sinus membrane during the lateral and crestal approaches to the grafting of the maxillary sinus floor. The technique involves the use of specially designed rotary instruments that plane away the bone in thinner layers, with less chance of excess bone removal and membrane perforation.


Assuntos
Aumento do Rebordo Alveolar/métodos , Complicações Intraoperatórias/prevenção & controle , Seio Maxilar/cirurgia , Mucosa Nasal/lesões , Osteotomia/métodos , Idoso , Substitutos Ósseos/uso terapêutico , Fosfatos de Cálcio/uso terapêutico , Materiais Revestidos Biocompatíveis/uso terapêutico , Tomografia Computadorizada de Feixe Cônico , Curetagem/instrumentação , Implantes Dentários , Durapatita/uso terapêutico , Feminino , Humanos , Arcada Edêntula/reabilitação , Arcada Edêntula/cirurgia , Masculino , Maxila/cirurgia , Pessoa de Meia-Idade , Osteotomia/instrumentação
19.
Acta Orthop Belg ; 77(2): 218-23, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21667734

RESUMO

Cervical disc prolapse has been traditionally treated with anterior discectomy and fusion, with good results; however autogenous bone graft and instrumentation remain a limiting factor. To avoid this, a stand-alone cage with bone marrow soaked tricalcium phosphate was used for single level cervical disc disease. Fifteen consecutive patients with single level cervical disc disease operated with the above technique were prospectively followed at six weeks, six and twelve months post-surgery. Clinical improvement was assessed by VAS and Odom's criteria. CT and plain radiography were used to assess fusion. Mean duration of symptoms was 7.2 months (SD: 4.14, range: 1-18 months). Mean preoperative VAS was 7 (SD: 131, range: 5-10) which improved to 1.4 (SD: 0.63, range: 1-3) at 6 weeks post op, 0.93 (SD: 0.80, range: 0-3) at 6 months and 0.80 (SD : 0.77, range : 0-3) at final follow-up. Similarly Odom's criteria were excellent in ten, good in three and satisfactory in 2 patients at six weeks. Results were rated excellent in eleven patients, good and satisfactory in two patients each respectively at six months and final follow-up. All patients had radiological fusion with no sign of cage extrusion. Results with this technique in terms of fusion, pain relief and overall functional outcomes were found to be good in this small patient population and warrant a larger sample size randomized long-term study.


Assuntos
Materiais Biocompatíveis/uso terapêutico , Substitutos Ósseos/uso terapêutico , Fosfatos de Cálcio/uso terapêutico , Discotomia/métodos , Fusão Vertebral/métodos , Adulto , Vértebras Cervicais/cirurgia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Medição da Dor , Resultado do Tratamento
20.
No Shinkei Geka ; 39(5): 491-5, 2011 May.
Artigo em Japonês | MEDLINE | ID: mdl-21512200

RESUMO

We report a case of cranial reconstruction using autologous split calvarial bone combined with calcium phosphate bone cement (CPC). A 19-years-old man suffered from cranium defect and rhinorrhea originating from frontal skull base fracture in a traffic accident. After CSF hydration treatment had finished, continuously we performed cranial reconstruction with autologous split calvarial bone so that the patient could return to work at an early stage. The use of autologous split calvarial bone with CPC was able to increase stability of the construct and provide excellent cosmetic result in our short follow up period. The combination use of these two materials may be useful for cranial reconstruction in patients with cranium defect.


Assuntos
Cimentos Ósseos/uso terapêutico , Fosfatos de Cálcio/uso terapêutico , Procedimentos de Cirurgia Plástica/métodos , Base do Crânio/lesões , Fraturas Cranianas/cirurgia , Crânio/cirurgia , Crânio/transplante , Acidentes de Trânsito , Humanos , Masculino , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA